ARCHIVES

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

This article is from The Cancer Letter archive.

Vol. 17 No. 33 | August 16, 1991

Download PDF Visit The Full Archive

Related Articles

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991

Roche Markets CMV Test in Europe

April 29, 2011

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

NCI-Approved Clinical Trials

December 29, 2006